Search

everythinglearnresearchcommunity

for

Search:↓

Scientists made the first metal-based compounds from a nonsteroidal antiandrogen drug, which showed potential in fighting both hormone-dependent and independent prostate cancer cells.

Norethisterone (jenapharm) therapy is effective for endometrial cancer.

GI197111X is best dissolved in Capmul MCM for trials.

Adding cerium(III) chloride to Grignard reagents improves the making of compounds that could treat prostate issues and hair loss.

Scientists made a carbon-14 labeled version of a drug with a 48% yield and over 99% purity.

Finasteride, a hair loss treatment, works better and is more stable when delivered through specially prepared gels, leading to increased hair growth.

A new method accurately measures DHEAS in blood, improving on current tests.

Canine hair follicle cells metabolize DHEA and testosterone differently than human cells.

Scientists have developed a new method to detect steroid abuse in athletes using cell-based tests, which could be the future of anti-doping methods.

The treatment improved acne, seborrhoea, and hirsutism, with some side effects like spotting and nervousness.

CYP154C7 enzyme can effectively modify steroids and is promising for commercial use.

4-azasteroids, including finasteride, can inhibit 5α-reductase, helping treat conditions like enlarged prostate and hair loss.

Curcumin and its derivatives can block an enzyme important for making testosterone, with one derivative being particularly strong.

The combination treatment reduced prostate size and improved testosterone deficiency symptoms but was less effective for sexual function.

Analyzing hair with this method can help understand and monitor scalp conditions and treatment effects.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

Adolescents with PCOS have higher levels of certain androgens, which are linked to hair growth but don't help diagnose PCOS better than testosterone levels.

DHEA therapy improved pubic hair growth and psychological well-being in young females with adrenal insufficiency.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

Depressed teens have different steroid levels in urine, which may help identify and treat them.

Women with PCOS have higher 5alpha-reductase activity, affecting steroid levels.

High doses of norethindrone acetate in rats caused various organ changes but didn't significantly increase tumor rates.

Methotrexate reduced the need for steroids in asthma patients without worsening their condition.

The research shows that hydrogen bonds greatly affect the crystal structure of a Finasteride derivative.

The method effectively measures drug impact on DHT levels in prostate treatments.

PM-9 and finasteride effectively inhibit the enzyme that converts testosterone to DHT.

Dexamethasone reduces inflammation and delays skin cell changes caused by TPA.

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.

A woman's hair loss and other symptoms were due to a rare hormone deficiency treatable with steroids.